Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 15/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | KIT | P10721 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25343704 | 0.85 | MAPK14 (0.56) | MAPK14CYP2D6CYP2C9CYP2C19L3MBTL1 | |
| SCHEMBL25341635 | 0.82 | MAPK14 (0.48) | MAPK14CYP2D6CYP2C9CYP2C19L3MBTL1 | |
| SCHEMBL25343661 | 0.81 | MAPK14 (0.44) | MAPK14CYP2D6CYP2C9CYP2C19CYP17A1 | |
| SCHEMBL4134853 | 0.80 | MAPK14 (0.52) | MAPK14CYP17A1CYP1A2 | |
| SCHEMBL4123815 | 0.75 | MAPK14 (0.72) | MAPK14CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL10624240 | 0.74 | L3MBTL1 (0.54) | MAPK14CYP2D6CYP2C9CYP2C19L3MBTL1 | |
| SCHEMBL31260837 | 0.71 | MAPK14 (0.39) | MAPK14CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL31260933 | 0.70 | PIK3CB (0.34) | MAPK14CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL1883322 | 0.69 | MAPK14 (0.44) | MAPK14CYP2D6CYP2C9CYP2C19L3MBTL1 | |
| SCHEMBL25343725 | 0.69 | CYP17A1 (0.46) | MAPK14L3MBTL1CYP17A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4472739-A1 | IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2024-12-11 | — | — | EP | disclosed |
| WO-2023148129-A1 | IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2023-08-10 | — | — | WO | disclosed |